£203.36

Springer Phosphodiesterases as Drug Targets: 204 (Handbook of Experimental Pharmacology, 204)

Price data last checked 39 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£203 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 52 days · 52 data points (no recent data)

Historical
Generating forecast…
£203.42 £203.35 £203.37 £203.38 £203.40 £203.41 £203.43 27 June 2026 09 July 2026 22 July 2026 04 August 2026 17 August 2026

Price Distribution

Price distribution over 52 days • 1 price levels

Days at Price
52 days 0 13 26 39 52 £203 Days at Price

Price Analysis

Most common price: £203 (52 days, 100.0%)

Price range: £203 - £203

Price levels: 1 different prices over 52 days

Description

Cyclic nucleotide phosphodiesterases (PDEs) are promising targets for pharmacological intervention. Multiple PDE genes, isoform diversity, selective expression and compartmentation of the isoforms, and an array of conformations of PDE proteins are properties that challenge development of drugs that selectively target this class of enzymes. Novel characteristics of PDEs are viewed as unique opportunities to increase specificity and selectivity when designing novel compounds for certain therapeutic indications. This chapter provides a summary of the major concepts related to the design and use of PDE inhibitors.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 November 2013
Listed Since
13 September 2013

Barcode

No barcode data available

Similar Products You Might Like

Phosphodiesterases and Their Inhibitors (Methods & Principles in Medicinal Chemistry)
81% match

Phosphodiesterases and Their Inhibitors (Methods & Principles in Medicinal Chemistry)

Wiley

£96.02 12 Aug 2026
Drug Delivery: 197 (Handbook of Experimental Pharmacology, 197)
76% match

Drug Delivery: 197 (Handbook of Experimental Pharmacology, 197)

Springer

£203.36 17 Aug 2026
Proteinkinase Inhibitors: 36 (Topics in Medicinal Chemistry, 36)
76% match

Proteinkinase Inhibitors: 36 (Topics in Medicinal Chemistry, 36)

Springer

£100.11 08 Aug 2026
Drug Delivery and Targeting: 284 (Handbook of Experimental Pharmacology, 284)
76% match

Drug Delivery and Targeting: 284 (Handbook of Experimental Pharmacology, 284)

Springer

£119.74 12 Sep 2026
The Nociceptin/Orphanin FQ Peptide Receptor: 254 (Handbook of Experimental Pharmacology, 254)
76% match

The Nociceptin/Orphanin FQ Peptide Receptor: 254 (Handbook of Experimental Pharmacology, 254)

Springer

£108.01 08 Aug 2026
Concepts and Principles of Pharmacology: 100 Years of the Handbook of Experimental Pharmacology: 260
75% match

Concepts and Principles of Pharmacology: 100 Years of the Handbook of Experimental Pharmacology: 260

Springer

£128.16 08 Aug 2026
Formulation, Characterization, and Stability of Protein Drugs: Case Histories: 9 (Pharmaceutical Biotechnology, 9)
75% match

Formulation, Characterization, and Stability of Protein Drugs: Case Histories: 9 (Pharmaceutical Biotechnology, 9)

Springer

£58.18 08 Aug 2026
Purinergic and Pyrimidinergic Signalling II: Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function: 151 / 2 (Handbook of Experimental Pharmacology, 151 / 2)
75% match

Purinergic and Pyrimidinergic Signalling II: Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function: 151 / 2 (Handbook of Experimental Pharmacology, 151 / 2)

Springer

£153.20 06 Aug 2026
Peptide and Protein Design for Biopharmaceutical Applications
75% match

Peptide and Protein Design for Biopharmaceutical Applications

Wiley

£97.01 08 Aug 2026
Applications of Pharmacokinetic Principles in Drug Development
75% match

Applications of Pharmacokinetic Principles in Drug Development

Springer

£77.49 06 Aug 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
75% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£77.88 06 Aug 2026
Drug Development: Molecular Targets for GI Diseases
75% match

Drug Development: Molecular Targets for GI Diseases

Humana

£76.42 08 Aug 2026
Pharmacology of Potassium Channels: 267 (Handbook of Experimental Pharmacology, 267)
74% match

Pharmacology of Potassium Channels: 267 (Handbook of Experimental Pharmacology, 267)

Springer

£108.75 12 Sep 2026
Polypharmacology in Drug Discovery
74% match

Polypharmacology in Drug Discovery

Wiley

£84.92 04 Aug 2026
Pharmacology of Drug Stereoisomers: 76 (Progress in Drug Research, 76)
74% match

Pharmacology of Drug Stereoisomers: 76 (Progress in Drug Research, 76)

Springer

£76.42 14 Sep 2026
Pharmacokinetics in Drug Development: Clinical Study Design and Analysis (Volume 1)
74% match

Pharmacokinetics in Drug Development: Clinical Study Design and Analysis (Volume 1)

Springer

£177.99 07 Aug 2026
Pediatric Pharmacotherapy: 261 (Handbook of Experimental Pharmacology, 261)
74% match

Pediatric Pharmacotherapy: 261 (Handbook of Experimental Pharmacology, 261)

Springer

£90.50 08 Sep 2026
Human Drug Targets: A Compendium for Pharmaceutical Discovery
74% match

Human Drug Targets: A Compendium for Pharmaceutical Discovery

Wiley

£95.59 06 Aug 2026
Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles: Volume 17 (Chemical Biology)
74% match

Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles: Volume 17 (Chemical Biology)

Royal Society of Chemistry

£151.05 04 Aug 2026
Cardiac Drug Development Guide (Methods in Pharmacology and Toxicology)
74% match

Cardiac Drug Development Guide (Methods in Pharmacology and Toxicology)

Humana

£77.49 07 Aug 2026
Peptide Chemistry and Drug Design
74% match

Peptide Chemistry and Drug Design

Wiley

£118.39 18 Aug 2026
Insights into Receptor Function and New Drug Development Targets (Research and Perspectives in Endocrine Interactions)
74% match

Insights into Receptor Function and New Drug Development Targets (Research and Perspectives in Endocrine Interactions)

Springer

£73.85 29 Jul 2026
Drug Target Selection and Validation: 1 (Computer-Aided Drug Discovery and Design, 1)
74% match

Drug Target Selection and Validation: 1 (Computer-Aided Drug Discovery and Design, 1)

Springer

£105.73 05 Aug 2026
PET for Drug Development and Evaluation: 26 (Developments in Nuclear Medicine, 26)
74% match

PET for Drug Development and Evaluation: 26 (Developments in Nuclear Medicine, 26)

Springer

£113.76 07 Aug 2026